Substance, use in relation to COVID-19: A scoping review.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
04 2022
Historique:
received: 27 04 2021
revised: 24 10 2021
accepted: 11 12 2021
pubmed: 28 12 2021
medline: 22 1 2022
entrez: 27 12 2021
Statut: ppublish

Résumé

We conducted a scoping review focused on various forms of substance use amid the pandemic, looking at both the impact of substance use on COVID-19 infection, severity, and vaccine uptake, as well as the impact that COVID-19 has had on substance use treatment and rates. A scoping review, compiling both peer-reviewed and grey literature, focusing on substance use and COVID-19 was conducted on September 15, 2020 and again in April 15, 2021 to capture any new studies. Three bibliographic databases (Web of Science Core Collection, Embase, PubMed) and several preprint servers (EuropePMC, bioRxiv, medRxiv, F1000, PeerJ Preprints, PsyArXiv, Research Square) were searched. We included English language original studies only. Of 1564 articles screened in the abstract and title screening phase, we included 111 research studies (peer-reviewed: 98, grey literature: 13) that met inclusion criteria. There was limited research on substance use other than those involving tobacco or alcohol. We noted that individuals engaging in substance use had increased risk for COVID-19 severity, and Black Americans with COVID-19 and who engaged in substance use had worse outcomes than white Americans. There were issues with treatment provision earlier in the pandemic, but increased use of telehealth as the pandemic progressed. COVID-19 anxiety was associated with increased substance use. Our scoping review of studies to date during COVID-19 uncovered notable research gaps namely the need for research efforts on vaccines, COVID-19 concerns such as anxiety and worry, and low- to middle-income countries (LMICs) and under-researched topics within substance use, and to explore the use of qualitative techniques and interventions where appropriate. We also noted that clinicians can screen and treat individuals exhibiting substance use to mitigate effects of the pandemic. Study was funded by the Institution for Social and Policy Studies, Yale University and The Horowitz Foundation for Social Policy. DH was funded by a NIDA grant (R01DA048860). The funding body had no role in the design, analysis, or interpretation of the data in the study.

Sections du résumé

BACKGROUND
We conducted a scoping review focused on various forms of substance use amid the pandemic, looking at both the impact of substance use on COVID-19 infection, severity, and vaccine uptake, as well as the impact that COVID-19 has had on substance use treatment and rates.
METHODS
A scoping review, compiling both peer-reviewed and grey literature, focusing on substance use and COVID-19 was conducted on September 15, 2020 and again in April 15, 2021 to capture any new studies. Three bibliographic databases (Web of Science Core Collection, Embase, PubMed) and several preprint servers (EuropePMC, bioRxiv, medRxiv, F1000, PeerJ Preprints, PsyArXiv, Research Square) were searched. We included English language original studies only.
RESULTS
Of 1564 articles screened in the abstract and title screening phase, we included 111 research studies (peer-reviewed: 98, grey literature: 13) that met inclusion criteria. There was limited research on substance use other than those involving tobacco or alcohol. We noted that individuals engaging in substance use had increased risk for COVID-19 severity, and Black Americans with COVID-19 and who engaged in substance use had worse outcomes than white Americans. There were issues with treatment provision earlier in the pandemic, but increased use of telehealth as the pandemic progressed. COVID-19 anxiety was associated with increased substance use.
CONCLUSIONS
Our scoping review of studies to date during COVID-19 uncovered notable research gaps namely the need for research efforts on vaccines, COVID-19 concerns such as anxiety and worry, and low- to middle-income countries (LMICs) and under-researched topics within substance use, and to explore the use of qualitative techniques and interventions where appropriate. We also noted that clinicians can screen and treat individuals exhibiting substance use to mitigate effects of the pandemic.
FUNDING
Study was funded by the Institution for Social and Policy Studies, Yale University and The Horowitz Foundation for Social Policy. DH was funded by a NIDA grant (R01DA048860). The funding body had no role in the design, analysis, or interpretation of the data in the study.

Identifiants

pubmed: 34959077
pii: S0306-4603(21)00398-1
doi: 10.1016/j.addbeh.2021.107213
pmc: PMC8684053
mid: NIHMS1767300
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107213

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA048860
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Ann Intern Med. 2020 Jul 7;173(1):57-58
pubmed: 32240283
Syst Rev. 2019 Nov 7;8(1):264
pubmed: 31699124
Cyberpsychol Behav Soc Netw. 2020 Dec;23(12):811-817
pubmed: 32757951
Alcohol Clin Exp Res. 2021 Apr;45(4):802-807
pubmed: 33667019
Int J Drug Policy. 2010 Nov;21(6):441-4
pubmed: 21051214
JBI Evid Synth. 2020 Oct;18(10):2119-2126
pubmed: 33038124
Basic Clin Neurosci. 2020 Mar-Apr;11(2):207-216
pubmed: 32855780
MMWR Morb Mortal Wkly Rep. 2021 Feb 05;70(5):162-166
pubmed: 33539336
Am J Manag Care. 2020 Jul 1;26(7):e202-e204
pubmed: 32672917
Tob Induc Dis. 2020 May 28;18:46
pubmed: 32489343
Asian J Psychiatr. 2020 Dec;54:102451
pubmed: 33271730
Psychiatry Clin Neurosci. 2020 Aug;74(8):440-441
pubmed: 32463127
Alcohol Res. 2015;37(2):159-70
pubmed: 26695755
J Community Health. 2021 Jun;46(3):471-475
pubmed: 32643078
J Perinatol. 2005 Jun;25(6):365-7
pubmed: 15915163
J Adolesc Health. 2020 Sep;67(3):354-361
pubmed: 32693983
Alcohol Alcohol. 2017 Jul 01;52(4):472-476
pubmed: 28371811
Psychiatry Res. 2020 Nov;293:113407
pubmed: 32827993
Public Health. 2020 Jun;183:6-7
pubmed: 32388011
BMJ. 1995 Jul 1;311(6996):42-5
pubmed: 7613329
Prev Med. 2021 Apr;145:106422
pubmed: 33422577
Nicotine Tob Res. 2020 Aug 24;22(9):1671-1672
pubmed: 32459837
AIDS Behav. 2021 Feb;25(2):354-359
pubmed: 32705370
J Addict Med. 2020 Jul/Aug;14(4):e1-e3
pubmed: 32412931
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
Am J Emerg Med. 2021 Mar;41:51-54
pubmed: 33387928
Psychother Psychosom. 2021;90(3):191-199
pubmed: 33212440
PLoS One. 2013;8(3):e59202
pubmed: 23544056
Stud Health Technol Inform. 2020 Jun 26;272:5-8
pubmed: 32604586
Addict Behav. 2020 Nov;110:106532
pubmed: 32652385
Int J Environ Res Public Health. 2020 Aug 28;17(17):
pubmed: 32872336
Nutrients. 2020 Jun 03;12(6):
pubmed: 32503173
Psychiatry Res. 2021 Feb;296:113676
pubmed: 33385782
Alcohol Alcohol. 2020 Jun 25;55(4):350-353
pubmed: 32400859
N Engl J Med. 2021 Jan 14;384(2):e6
pubmed: 33378604
Psychiatry Clin Neurosci. 2020 Oct;74(10):550-551
pubmed: 32779866
Drug Alcohol Depend. 2020 Sep 1;214:108176
pubmed: 32717504
Int J Hosp Manag. 2021 Aug;97:102992
pubmed: 36317000
JAMA Psychiatry. 2021 Apr 1;78(4):372-379
pubmed: 33533876
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Intern Med. 2021 Apr;289(4):574-583
pubmed: 33270312
Front Psychiatry. 2020 Dec 16;11:620612
pubmed: 33391060
J Public Health (Oxf). 2021 Apr 12;43(1):9-12
pubmed: 33103716
Nicotine Tob Res. 2020 Aug 24;22(9):1662-1663
pubmed: 32343816
J Subst Abuse Treat. 2020 Nov;118:108124
pubmed: 32893047
Psychiatry Clin Neurosci. 2020 Oct;74(10):542-549
pubmed: 32602150
J Clin Epidemiol. 2020 Feb;118:42-54
pubmed: 31698064
Am J Drug Alcohol Abuse. 2021 Mar 4;47(2):154-159
pubmed: 33481639
Lancet Microbe. 2020 Jun;1(2):e64
pubmed: 32835333
J Adolesc Health. 2021 Apr;68(4):658-665
pubmed: 33781471
Tob Control. 2021 Nov;30(6):696-699
pubmed: 32855353
Trans R Soc Trop Med Hyg. 2021 Jul 1;115(7):820-831
pubmed: 33444432
J Public Health (Oxf). 2020 Aug 18;42(3):461-465
pubmed: 32643751
J Addict Med. 2020 Dec;14(6):e366-e368
pubmed: 33009166
J Subst Abuse Treat. 2021 Oct;129:108385
pubmed: 34080553
JAMA Psychiatry. 2020 Sep 1;:
pubmed: 32870241
Drug Alcohol Rev. 2021 Feb;40(2):183-191
pubmed: 33170976
Alcohol. 2020 Nov;88:29-32
pubmed: 32693023
Health Psychol Res. 2020 May 27;8(1):9124
pubmed: 32529094
Drug Alcohol Depend. 2021 Mar 1;220:108519
pubmed: 33461150
Drug Alcohol Rev. 2020 Jul;39(5):435-440
pubmed: 32483882
Addict Behav. 2021 Mar;114:106754
pubmed: 33310690
BMC Med Res Methodol. 2018 Nov 19;18(1):143
pubmed: 30453902
Clin Infect Dis. 2021 Feb 16;72(4):703-706
pubmed: 32562416
J Psychoactive Drugs. 2021 Jan-Mar;53(1):1-9
pubmed: 33111650
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Drug Alcohol Depend. 2020 May 1;210:107958
pubmed: 32203863
Lancet. 2019 Jan 19;393(10168):210-211
pubmed: 30663582
Nicotine Tob Res. 2020 Aug 24;22(9):1646-1649
pubmed: 32609839
Psychiatr Serv. 2021 May 1;72(5):578-581
pubmed: 33138712
Lancet Public Health. 2020 May;5(5):e259
pubmed: 32277874
Hum Vaccin Immunother. 2018 Jul 3;14(7):1654-1659
pubmed: 29553872
Addiction. 2021 May;116(5):1186-1195
pubmed: 32918300
Drug Alcohol Depend. 2021 Apr 1;221:108590
pubmed: 33631546
Front Psychiatry. 2021 Apr 29;12:639393
pubmed: 34025471
Psychiatr Serv. 2020 Dec 1;71(12):1214-1215
pubmed: 32781928
Subst Abus. 2020;41(3):286-291
pubmed: 32697172
PLoS One. 2020 Dec 22;15(12):e0238552
pubmed: 33351817
Mol Psychiatry. 2021 Jan;26(1):30-39
pubmed: 32929211
J Epidemiol Community Health. 2021 Mar;75(3):224-231
pubmed: 32978210
J Stud Alcohol Drugs. 2022 May;83(3):352-357
pubmed: 35590175
Lancet Psychiatry. 2019 Nov;6(11):961-966
pubmed: 31327707
Alcohol Alcohol. 2020 Oct 20;55(6):698-699
pubmed: 32556079
J Am Psychiatr Nurses Assoc. 2020 Mar/Apr;26(2):172-180
pubmed: 30866701
Tob Control. 2021 Dec;30(e2):e111-e121
pubmed: 32826387
Qual Health Res. 2020 Dec;30(14):2192-2204
pubmed: 32865149
Int J Environ Res Public Health. 2020 Jun 29;17(13):
pubmed: 32610613
Lancet Gastroenterol Hepatol. 2020 Oct;5(10):886-887
pubmed: 32763197
JAMA Netw Open. 2020 Sep 1;3(9):e2022942
pubmed: 32990735
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070
pubmed: 32800868
Z Gesundh Wiss. 2022;30(8):2069-2079
pubmed: 33996384
Nicotine Tob Res. 2021 Mar 19;23(4):765-769
pubmed: 33029618
Nicotine Tob Res. 2021 Aug 18;23(9):1617-1622
pubmed: 33782707
J Addict Med. 2020 Jul/Aug;14(4):e136-e138
pubmed: 32433364
Neuropsychopharmacology. 2018 Jan;43(1):195-212
pubmed: 28853439
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057
pubmed: 32790653
Int J Environ Res Public Health. 2021 Jan 24;18(3):
pubmed: 33498834
Alcohol Clin Exp Res. 2020 Oct;44(10):2073-2083
pubmed: 32870516
JAMA Netw Open. 2021 Jan 4;4(1):e2034878
pubmed: 33475751
Drug Alcohol Depend. 2021 May 1;222:108672
pubmed: 33757708
J Adolesc Health. 2020 Oct;67(4):519-523
pubmed: 32798097
Thorax. 2021 Jul;76(7):714-722
pubmed: 33402392
Lancet. 2020 Apr 25;395(10233):1322-1325
pubmed: 32247324
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Int J Drug Policy. 2021 Jun;92:103140
pubmed: 33558165
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
Psychiatry Res. 2020 Jul;289:113096
pubmed: 32405115
Int J Drug Policy. 2021 Jul;93:102904
pubmed: 32861536
JMIR Mhealth Uhealth. 2020 Jun 11;8(6):e19494
pubmed: 32463375
J Epidemiol. 2021 Jun 5;31(6):378-386
pubmed: 33746148
J Adolesc Health. 2020 Oct;67(4):603-605
pubmed: 32792255
Nicotine Tob Res. 2021 Jun 8;23(7):1254-1258
pubmed: 33782699
J Addict Med. 2020 Sep/Oct;14(5):e257-e260
pubmed: 32868681
Tob Induc Dis. 2020 Jul 27;18:63
pubmed: 32733178
Basic Clin Neurosci. 2020 Mar-Apr;11(2):155-162
pubmed: 32855774
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Addict Behav. 2021 Feb;113:106661
pubmed: 33038682
Syst Rev. 2021 Feb 3;10(1):48
pubmed: 33536070
Subst Abus. 2020;41(3):269-274
pubmed: 32697171
Subst Abus. 2020;41(4):409-412
pubmed: 33044893
Drug Alcohol Depend. 2021 Jan 1;218:108438
pubmed: 33271434
Front Psychiatry. 2021 Aug 06;12:646206
pubmed: 34421664
JAMA Psychiatry. 2020 Feb 1;77(2):165-171
pubmed: 31722000
Intern Emerg Med. 2020 Aug;15(5):845-852
pubmed: 32385628
J Subst Abuse Treat. 2021 Jan;120:108155
pubmed: 33298297
Eur Child Adolesc Psychiatry. 2021 Aug 21;:
pubmed: 34417875
J Med Internet Res. 2020 Oct 30;22(10):e21743
pubmed: 33001829
Prev Chronic Dis. 2016 Oct 13;13:E145
pubmed: 27736053
Int J Technol Assess Health Care. 2012 Apr;28(2):138-44
pubmed: 22559755
Subst Use Misuse. 2020;55(11):1902-1904
pubmed: 32666857
Science. 2020 Jul 24;369(6502):413-422
pubmed: 32532802
Ann Intern Med. 2020 Jul 7;173(1):61-62
pubmed: 32240293
Addict Behav. 2021 Apr;115:106783
pubmed: 33360444
J Subst Abuse Treat. 2021 Oct;129:108378
pubmed: 34080549
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Addict Behav. 2020 Nov;110:106527
pubmed: 32679435
Gen Psychiatr. 2020 Jul 8;33(4):e100252
pubmed: 34192233
J R Soc Interface. 2008 Dec 6;5(29):1505-8
pubmed: 18713723
Front Public Health. 2021 Mar 04;9:634396
pubmed: 33748068
Int J Ment Health Addict. 2022;20(1):316-323
pubmed: 32837438
J Homosex. 2021 Mar 21;68(4):631-646
pubmed: 33439793
Int J Ment Health Addict. 2021;19(6):2362-2368
pubmed: 32837418
Psychiatry Res. 2021 Feb;296:113706
pubmed: 33482422
Drug Alcohol Depend. 2020 Nov 1;216:108260
pubmed: 32890975
Int J Environ Res Public Health. 2020 Jun 07;17(11):
pubmed: 32517294
Alcohol Alcohol. 2020 Oct 20;55(6):702-704
pubmed: 32959877
Australas Psychiatry. 2020 Oct;28(5):524-526
pubmed: 32722961
JMIR Ment Health. 2021 Feb 8;8(2):e25835
pubmed: 33481760
Sultan Qaboos Univ Med J. 2008 Mar;8(1):11-9
pubmed: 21654952
Neuropsychopharmacology. 2021 May;46(6):1068-1070
pubmed: 33479513
JMIR Public Health Surveill. 2020 Sep 18;6(3):e19630
pubmed: 32589149
Rehabil Psychol. 2020 Aug;65(3):193-198
pubmed: 32406739
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
J Subst Abuse Treat. 2021 Aug;127:108367
pubmed: 34134871
J Med Internet Res. 2014 Jun 02;16(6):e142
pubmed: 24892426
Int J Cardiol. 2021 Jan 15;323:285-287
pubmed: 32889019
PLoS One. 2017 May 22;12(5):e0177388
pubmed: 28531176
Drug Alcohol Depend. 2021 Feb 1;219:108488
pubmed: 33383352
PLoS One. 2014 Oct 02;9(9):e108787
pubmed: 25275315
Front Psychiatry. 2020 Oct 30;11:574676
pubmed: 33192708
Am J Epidemiol. 2002 Jun 1;155(11):988-96
pubmed: 12034577
J Med Virol. 2021 Mar;93(3):1556-1567
pubmed: 32886365
Am J Addict. 2020 May;29(3):174-175
pubmed: 32281130
Ann Intern Med. 2021 Jul;174(7):1027-1029
pubmed: 33646843
Int J Environ Res Public Health. 2020 Jul 25;17(15):
pubmed: 32722469
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
Am J Public Health. 2020 Apr;110(4):509-516
pubmed: 32078347
Int J Environ Res Public Health. 2021 Jan 09;18(2):
pubmed: 33435462
J Clin Invest. 2019 Oct 1;129(10):4290-4304
pubmed: 31483291
J Med Virol. 2021 Feb;93(2):1045-1056
pubmed: 32749705
Hepatology. 2020 Sep;72(3):1102-1108
pubmed: 32369624

Auteurs

Navin Kumar (N)

Human Nature Lab, Department of Sociology, Yale University, New Haven, CT, USA. Electronic address: navin.kumar@yale.edu.

Kamila Janmohamed (K)

Yale College, New Haven, CT, USA.

Kate Nyhan (K)

Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, USA; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.

Silvia S Martins (SS)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Magdalena Cerda (M)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.

Deborah Hasin (D)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Jenny Scott (J)

Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.

Afia Sarpong Frimpong (A)

Yale College, New Haven, CT, USA.

Richard Pates (R)

Institute of Health and Society, University of Worcester, Worcester, UK.

Lilian A Ghandour (LA)

Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.

Mayyada Wazaify (M)

Department of Biopharmaceuticals and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.

Kaveh Khoshnood (K)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH